Searched for
MANKIND RESEARCH CENTRE
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- Mankind gets CDSCO nod for Phase 1 clinical trials for molecule to treat autoimmune disordersMankind Pharma has received CDSCO approval to begin Phase 1 clinical trials for MKP11093, a molecule targeting multiple autoimmune disorder...
- Resilience and ambition have got us to where we are today, say Mankind’s Juneja brothersIntroducing pocket-friendly medicines in a price-sensitive market like India was a revolutionary strategy that made a big difference. "It t...
- ET Awards for Corporate Excellence: Rx Meerut: Mankind Pharma's bottom-up journey to the leader boardThe company has for the last five years been ranked number one in the number of prescriptions. Manforce condoms, oral contraceptives Prega ...
- 31% listing day pop! Time to book profits in Mankind Pharma shares?Its shares are currently trading nearly 6.7% higher at Rs 1,387. The IPO received a strong response, with the issue subscribed for 15.32 ti...
- Mankind Pharma shares list at 20% premium over IPO priceThe IPO, valued at Rs 4,326 crore, received an overwhelming response, being subscribed for 15.32 times due to interest from qualified insti...
- Mankind Pharma set for stellar debut on Tuesday, Street sees 8-10% listing premiumMankind Pharma's shares are commanding a premium of Rs 100-113 to its issue price of Rs 1,080 in the grey market. Research analysts predict...
- Mankind Pharma IPO: 10 things to know about the biggest issue so far this yearIndian pharma company Mankind Pharma is set to open its IPO next week. The offer for sale of 40 million equity shares by promoters and othe...
- Mankind setting up Rs 300-crore unit to manufacture fertility hormoneMankind is investing about ₹250-₹300 crore on the Udaipur unit that is expected to begin operations by September-October this year. The uni...
- Working to introduce integrative medicine in all hospitals: Union Health MinisterNoting that research should not be restricted to government laboratories alone, the union minister said the Centre wants to open research t...
- Scientists find new way to produce hydrogen fuel from sunlightBengaluru, April 28 (IANS) The energy provided by sunlight in an hour is equivalent to mankind's total energy consumption for one year, but...
- Space Pavilion of ISRO, VSSC opened at CUSATThe ultimate goal of scientific research should be the benefit of mankind as well as nature, Vikram Sarabhai Space Centre Director M C Dath...
- Omar Abdullah calls for open science,liberal dissemination of knowledgeOmar said while patents on innovations may give a sense of ownership to the innovation and science entrepreneur, the benefits of science sh...
- Top global space meet COSPAR takes off in MysoreScientists from 74 nations gathered today for a 9-day mega meet that will discuss contemporary topics in the realm of space.
- IT experts urge worldwide governments to promote use of free softwareInternational IT experts have urged governments worldwide to promote the use of open source software as a cost-effective option.
- Global warming may reduce wheat outputThe implications of global warming, already described as the greatest challenge for mankind in the 21st century, could be particularly seve...
- India seen as vulnerable to global warming impactThe implications of global warming, already described as the greatest challenge for mankind in the 21st century, could be particularly seve...
- Mankind Pharma eyes upto 10% equity saleUnlisted drug maker Mankind Pharma Ltd hopes this year to sell upto 10 per cent of its equity to domestic investors in a bid to raise funds...
- Mankind Pharma in talks with PE funds to offload 5% stakeDelhi-based Mankind Pharma is holding parleys with some of the leading private equity funds for a private placement deal.
Load More
